Official: US to spend $3B for antiviral pills for COVID-19
The United States is devoting more than $3 billion to advance development of antiviral pills for COVID-19
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The United States is devoting more than $3 billion to advance development of antiviral pills for COVID-19, according to an official briefed on the matter.
The pills, which would be used to minimize symptoms after infection, are in development and could begin arriving by year's end, pending the completion of clinical trials.
The White House is scheduled to hold a briefing on its COVID-19 plans with Dr. Anthony Fauci the nation's top infectious disease expert.
News of the administration's plans for the pill was first reported Thursday by The New York Times The official who confirmed the report spoke on the condition of anonymity ahead of an announcement.